bpc-157 tb500 what are they & TB-500 Blend (1:1) BPC-157 (10 mg) + TB-500

Chronic Injury Timeline Chronic injuries present greater challenges and require extended timelines

Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence Summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee pain retrospective (2021, n=17): 91.6% reported significant improvement No large-scale controlled trials published Safety: No immunosuppression or hormonal disruption in available data 2025 systematic review (HSS Journal): recommends caution due to limited high-quality clinical evidence 2025 narrative review: flags theoretical pathologic angiogenesis risk Stable in gastric acid (oral administration viable) No observed toxicity at therapeutic doses in published reports Foundational Reviews Sikiric P, Seiwerth S, et al

Areas We Serve in Miami & South Florida Our clinic at 24 NW 29th Street is in Wynwood & Midtown, minutes from Edgewater and Brickell

It's an extra layer of protection

The science behind BPC-157 involves several interconnected mechanisms that, taken together, create a more favorable environment for tissue repair

Eating before injection does not make CJC-1295 dangerous